Outcome measures and significance of the comparison between electrophysical modalities. by Ena Bula-Oyola (10325646)

Outcome measures and significance of electrophysical modalities versus splinting. by Ena Bula-Oyola (10325646)

Outcome measures and significance of electrophysical modalities versus placebo. by Ena Bula-Oyola (10325646)

Mean percentage changes (95% CI) in total testosterone, SHBG and free testosterone (mITT analysis). by Chanel Avenant (409756)

Subjects:

Percentage of US adults with health insurance coverage by income-level, age 60 to 70 years. by Rahul Aggarwal (4428457)

Subjects:

Schematic representation of the study protocol. by Neng Pan (5262032)

Subjects:

Baseline characteristics. by Neng Pan (5262032)

Subjects:

Comparison within groups. by Neng Pan (5262032)

Subjects:

Comparison before and after the experiment in each group. by Neng Pan (5262032)

Subjects:

Data ste. by Neng Pan (5262032)

Subjects:

Comparison of data after the experiment. by Neng Pan (5262032)

Subjects:

Correlation diagram of each parameter in each group. by Neng Pan (5262032)

Subjects:

Recruitment process. by Neng Pan (5262032)

Subjects:

Chamber system for the gaseous emission measurement from manure sun-drying. by Van Thanh Nguyen (9706481)

Subjects:

Measured parameters of the fabricated LZCM composites. by Md. Abu Daud (21485629)

Subjects:

Mean and SDs of the significant regions. by Faran Sabeti (6166766)

Subjects:

Outcome measures and significance of electrophysical modalities versus manual therapy. by Ena Bula-Oyola (10325646)

Location of 4 somatic measurement sites. by Yongliang Jiang (6200549)

“…Regarding the thermal characteristics, compared with the healthy control group, the temperature of the somatic sites of the heart meridian (Shenmen(HT7)/Shaohai(HT3)), as well as Taiyuan (LU9) of the lung meridian, increased significantly (<i><i>P</i></i> < 0.05). With regard to the metabolic features, rSO₂ of the somatic site of the heart meridian (Shaohai (HT3)) in the CSAP group decreased significantly (<i><i>P</i></i> < 0.05) as compared to the healthy control group. …”

Significant outcome measures. by Patricia García-Pérez (19443332)

“…</p><p>Results</p><p>Participants in the intervention group showed a significant better evolution in the main outcome measure of quality of life (SAQOL-39 <i>p</i> = .029), as well as for independence (mRS<i>p</i> = .004), perceptual-cognitive skills (MoCA <i>p</i> = .012)and symptoms of depression (BDI-II <i>p</i> = .011) compared to the control group.…”

Number of significant genes and fold change. by Gordon A. Barr (11163243)